AzTrials
AzTrials

OverweightNCT05000437

The Effectiveness and Safety of HIIT in Overweight Male Subjects

A study testing HIIT in people with Overweight and Overweight or Obesity, run by Universitas Indonesia at 2 sites in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Increased prevalence of overweight and obesity is one of the main health problems recently. Energy balance from nutrition intake and energy expenditure through physical activity, especially structured physical activity, is needed to prevent overweight individuals become obese individuals. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
Conditions the study is for
Overweight, Overweight or Obesity
What is being tested?
HIIT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
2 sitesIndonesia
Study dates
1 Nov 2020to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • overweight (BMI 25 - 29,9)
  • live in Jakarta and greater area
  • willing to participate

Who cannot join

  • smoking
  • any medical health problems (epilepsy, cardiovascular disease, kidney and liver problems, history of fractures, tendon and ligament injuries)

Trial locations and contacts

2 sites in 1 country.

Indonesia2 sites
  • Fakultas Kedokteran Universitas Indonesia

    Jakarta Pusat, DKI Jakarta, 10430

  • Universitas Indonesia

    Jakarta Pusat, DKI Jakarta, 10430

Other trials in Indonesia

About this study

Official title: The Effectiveness and Safety of High Intensity Interval Training Based on Oxidative Stress and Inflammatory Markers in the Management of Overweight Male Subjects

Increased prevalence of overweight and obesity is one of the main health problems recently. Energy balance from nutrition intake and energy expenditure through physical activity, especially structured physical activity, is needed to prevent overweight individuals become obese individuals. This research objective is to explore the effectiveness and safety of structured high intensity interval training in male young adults subjects with overweight based on change of body composition, oxidative stress and inflammatory markers. This research used experimental model to test structured high intensity interval training program with pre-post test in single group. Comprehensive analysis of training effect in this research consists of measurement of several parameters, such as body composition, inflammatory markers, and oxidative stress markers as the benchmark of training safety. Browning white adipose tissue and cognitive function are complement parameters to the assessment of training effectiveness. Daily food record and physical activity for 3 x 24 hours will be carried out periodically to control confounding factors.

Read the detailed description
  • Subjects are recruited via e-flyer distributed online across university departments. Individual who is interested in study participation fills out screening form. Research assistants screen subjects eligibility. Subjects are coded based on the order of screening form fulfillment.
  • Research assistants are using the standard operational procedures for each assessments. Training for the research assistants precedes the data collection to ensure the similarity of understanding and skills during measurements. One research assistant responsible for scheduling the assessments and training sessions. Continuous evaluation are planned weekly to provide room for improvements in the process of data collection.
  • Sample size assessment is measured from 5 primary output by a research assistants using sample size calculation website for single intervention clinical trial.
  • Investigator use paper based data collection for each assessment and during training sessions. Subject are encouraged to report any symptoms and signs during intervention period in each meeting with the research assistants or via online messaging. Any reports will be documented in separated form. One research assistant makes sure the data fields are completed in each measurements and during training sessions. The assistant also check the similarity of the data entered in the master table.
  • Data analysis will be lead by one research assistant using newest version of SPSS software. The analysis will be started after the baseline measurement is completed although the data collection is not finished. All numeric data will be presented as mean and standard deviations if normally distributed or median and minimum maximum range if not normally distributed. Paired t-test will be used to identify the difference before and after the intervention if the data are normally distributed. If the data are not normally distributed, Wilcoxon test will be used to identify the difference before and after the intervention.

To ensure that there is no missing data, the research assistant who responsible for data completeness will perform daily checking. Any missing data will be stated and immediately completed. Research assistants will provide close supervision for each subject to ensure the delivery of all necessary reports.

Being tested
HIIT
Keywords
high intensity interval training, overweight, young male
Medical subject headings
Overweight, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HIITOther

    3x/week high intensity interval training for 12 weeks

Study groups in NCT05000437
Study groupRoleWhat they receive
High Intensity Interval TrainingExperimentalsingle arm intervention, with high intensity interval training
Receives: Other: HIIT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cardiorespiratory fitness

    VO2Max in ml/kg/minute

    Measured: 12 weeks

  2. body mass index

    weight and height combined as BMI in kg/m2

    Measured: week 4

  3. body mass index

    weight and height combined as BMI in kg/m2

    Measured: week 8

  4. body mass index

    weight and height combined as BMI in kg/m2

    Measured: week 12

  5. body fat mass

    total fat mass in the body as percentage

    Measured: week 4

  6. body fat mass

    total fat mass in the body as percentage

    Measured: week 8

  7. body fat mass

    total fat mass in the body as percentage

    Measured: week 12

  8. visceral fat

    body fat stored within abdominal cavity as ratings

    Measured: week 4

  9. visceral fat

    body fat stored within abdominal cavity as ratings

    Measured: week 8

  10. visceral fat

    body fat stored within abdominal cavity as ratings

    Measured: week 12

  11. waist circumference

    circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm

    Measured: week 4

  12. waist circumference

    circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm

    Measured: week 8

  13. waist circumference

    circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm

    Measured: week 12

  14. lipid profile

    total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride

    Measured: 12 weeks

  15. antioxidant level

    SOD in U/mg

    Measured: 12 weeks

  16. free radicals level

    MDA in nmol/mg

    Measured: 12 weeks

  17. inflammation

    TNF-alpha in microgram/ml

    Measured: 12 weeks

  18. interleukin level

    IL-6 nanogram/ml

    Measured: 12 weeks

Secondary outcomes (5)
  1. Fat Burning Effect

    FGF21

    Measured: week 1, 6, 12

  2. Myokin

    Irisin

    Measured: week 1, 6, 12

  3. Cognitive Function Screening

    Montreal Cognitive Assessment as score

    Measured: week 1 and 12

  4. Working memory Capacity

    N-Back test as percentage of correct answers

    Measured: week 1 and 12

  5. Executive Function

    Trail Making Test A and B as seconds

    Measured: week 1 and 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2021
  2. Study start1 Nov 2020
  3. Primary completion30 Oct 2021
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05000437
Sponsor's protocol ID
20-09-1081
Status last verified
Mar 2023
First submitted
29 May 2021
Last updated
8 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing HIIT in people with Overweight and Overweight or Obesity, run by Universitas Indonesia at 2 sites in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cardiorespiratory fitness (time frame: 12 weeks). The study lists 18 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in